Use of tansagem, as a mouthwash, in cancer-related lesions

Use of Plantago major L. extract rinse in oral mucositis related to Cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

REBEC

Registry ID

RBR-92784wr

Enrollment

Unknown

Registered

2024-01-30

Start date

2023-03-20

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis

Interventions

To formulate and evaluate the effects of a mouthwash with Plantago major L. extract (tansage) applied as a mouthwash in patients with chemotherapy-induced mucositis. The intervention took place throug

D25.583

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male and/or female patients diagnosed with cancer undergoing chemotherapy; over 18 years old; who have some degree of mucositis according to the World Health Organization

Exclusion criteria

Exclusion criteria: Pacients who had hematological disorders; were undergoing treatment with antibiotics, antivirals, antifungals or monoclonal drugs; who had some type of allergy to the components of rinse formulations ; who had previously undergone laser therapy for mucositis lesions

Design outcomes

Primary

Measure	Time frame
Expected outcome 1: It is expected to improve the quality of life of patients with oral mucositis induced by chemotherapy and radiotherapy during cancer treatment, using a mouthwash based on Plantago major L extract	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Brazil

Contacts

Public ContactLeocádia Fagundes

Universidade Federal da Fronteira Sul - UFFS

leocadiabrufati@hotmail.com+55(46)991119783

Outcome results

None listed

Source: REBEC (via WHO ICTRP)